2 promising small-cap growth stocks to stash in your ISA

Paul Summers takes a closer look at two last-minute small-cap options for your ISA.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Daffodils in the grass

Image source: Getty Images

Risk-tolerant? Some ISA allowance left to spend? So long as you can stand a bit of share price volatility, it can often be more profitable to look lower down the market spectrum. Thanks to their potential to grow faster than your average FTSE 350 company, small-cap stocks have the ability to seriously improve your wealth over a relatively short period of time.

Here are just a couple of such businesses — one of which I already have a position in.

In rude health

Know a keen cyclist or someone training for a marathon? If so, it’s likely that they’re already aware of (and possibly use) the products of AIM-listed sports nutrition specialist Science in Sport (LSE: SIS). 

While the share price hasn’t really budged today, there was nothing in this morning’s final results to cause concern to this market minnow’s owners. Quite the opposite.

Revenues rose by a satisfying 28% in 2017 to £15.6m — significantly outpacing forecasts for the sector as a whole for the fifth consecutive year. Positively, 27% of the former (£900,000) came from new products.

In line with the company’s plans to crack markets such as US and Italy, performance overseas was strong and accounted for 28% of all sales in 2017. Online growth was also stellar. No less than 55% of revenue came from its website last year, outperforming management’s own 50% target.

In addition to the above, I’m also encouraged by the brand partnerships developed over the last year with bodies such as British Cycling and USA Triathlon. The recruitment of Olympic champion swimmer Adam Peaty as an ambassador won’t do any harm and nor will the recently signed three-year deal with one of the biggest football clubs in the world — Manchester United.

Possessing a “strong launch pipeline for 2018” and a sizeable cash position of £16.6m (following a placing last November), I continue to believe that Science in Sport has a promising future, even if ongoing investment means that the company emerged from last year with an underlying operating loss of £1.7m.

Record growth

For something completely different, consider laser-guided equipment manufacturer Somero Enterprises (LSE: SOM). Since I became bullish on the company a year ago, the stock has registered a very satisfying 35% gain. How many FTSE 350 companies do you know that have done something similar?

Last week’s expectation-beating full-year results received a favourable reaction from investors and understandably so. Revenue grew 8% to a record $85.6m over 2017, with adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) rising by 14% to $28m. 

Like Science in Sport, Somero reported an increased proportion of sales coming from international markets with new products also contributing “meaningfully” to growth.

2018 could prove to be another great year for the small-cap. In addition to commenting on the company getting ever closer to achieving its $90m revenue target set in 2014, CEO Jack Cooney has also highlighted the £216m cap’s desire to exploit “a broad range of opportunities in related products and new markets“. With this in mind, Somero’s forthcoming move into a new leased facility in Chesterfield at some point in the second quarter to “accommodate growth” looks wholly appropriate.

Taking into account the above, its lack of debt (net cash position of $19m), still-fairly reasonable valuation (15 times earnings) and a recent 40% hike to the total dividend, Somero still warrants attention in my view.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be considered so you should consider taking independent financial advice.

Paul Summers owns shares in Science in Sport. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Content white businesswoman being congratulated by colleagues at her retirement party
Investing Articles

How I’d invest £5,000 in FTSE 100 shares to aim for a million

The FTSE 100 is home to many potential gems. Our writer considers if he can reach millionaire status by uncovering…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

How I’m aiming to become a Stocks and Shares ISA millionaire!

The Stocks and Shares ISA is an excellent vehicle for investments. In fact, many investors have become ISA millionaires. Here's…

Read more »

Mixed-race female couple enjoying themselves on a walk
Investing Articles

The Scottish Mortgage share price is on the up! Here’s why I’d buy

After a poor first half of the year, the Scottish Mortgage share price is beginning to rise. Here, this Fool…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

Should I be grabbing cheap Lloyds shares?

Lloyds shares have underperformed in recent years. Here, this Fool explains why he's still considering the stock for his portfolio.

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

How I’m using UK dividend shares to try and turn £20,000 into £100,000

Our writer has ambitious investment goals -- and patience. Here he explains how he's buying UK dividend shares to try…

Read more »

Middle-aged lady in wheelchair writing on whiteboard
Investing Articles

I’m taking a defensive stance by investing in the FTSE ahead of the recession

The FTSE has outperformed several indices in 2022, including the S&P 500. Jacob Ambrose Willson believes it can be used…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

Should I buy BP shares today?

BP is generating huge profits right now. Here, Edward Sheldon looks at whether he should buy shares in the oil…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Should I buy Rolls-Royce shares after the latest results?

Jon Smith runs over the key points from half-year results for Rolls-Royce shares to see if any green shoots are…

Read more »